Aurora, CO 的 三陰性乳癌 臨床試驗
9 項針對 三陰性乳癌 的研究正在 Aurora（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
招募中1/2 期
- University of Colorado Denver, Aurora
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- University of Colorado Cancer Center, Aurora
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
招募中2 期
- UCHealth University of Colorado Hospital, Aurora
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
招募中2/3 期
- Local Institution - 0289, Aurora
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
招募中2 期
- University of Colorado Cancer Center, Aurora
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
招募中1 期
- Anschutz Medical Center, Aurora
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
招募中1/2 期
- University of Colorado Cancer Center, Aurora
A Study of NX-1607 in Adults With Advanced Malignancies
招募中1 期
- University of Colorado School of Medicine, Aurora
CtDNA Based MRD Testing for NAC Monitoring in TNBC
招募中觀察性研究
- University of Colorado Cancer Center, Aurora
其他城市的 三陰性乳癌 試驗
- Houston, TX42 項研究
- New York City, NY31 項研究
- Nashville, TN28 項研究
- Los Angeles, CA27 項研究
- Boston, MA26 項研究
- San Antonio, TX23 項研究
- St. Louis, MO21 項研究
- Arlington, VA20 項研究
- Atlanta, GA20 項研究
- Dallas, TX18 項研究
- Chicago, IL16 項研究
- Columbus, OH16 項研究
Aurora 的其他研究
- 癌症（所有類型）35 項研究
- 大腸直腸癌32 項研究
- 非小細胞肺癌31 項研究
- 乳癌28 項研究
- 卵巢癌25 項研究
- 轉移性癌症25 項研究
- 第一型糖尿病23 項研究
- 肥胖症22 項研究
- 前列腺癌19 項研究
- 肺癌19 項研究
- 心臟衰竭18 項研究
- 黑色素瘤18 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。